4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-037364
Chief Financial Officer bought 300 shares at $6.95 ($2,085)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2017-05-31 | Purchase | +300 | $6.95 | $2,085 | 14,947 | D |
| Open-market purchases · 300 sh · avg $6.95 · $2,085 | |||||||
Loading xslF345X03/doc4.xml…